bucindolol [Ligand Id: 13193] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL321582 (Bucindolol)
  • Organic cation transporter 1/Solute carrier family 22 member 1 in Human [ChEMBL: CHEMBL5685] [GtoPdb: 1019] [UniProtKB: O15245]
There should be some charts here, you may need to enable JavaScript!
  • β1-adrenoceptor in Human [GtoPdb: 28] [UniProtKB: P08588]
There should be some charts here, you may need to enable JavaScript!
  • β2-adrenoceptor in Human [GtoPdb: 29] [UniProtKB: P07550]
There should be some charts here, you may need to enable JavaScript!
  • β3-adrenoceptor in Human [GtoPdb: 30] [UniProtKB: P13945]
  • β3-adrenoceptor in Mouse [GtoPdb: 30] [UniProtKB: P25962]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Organic cation transporter 1/Solute carrier family 22 member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5685] [GtoPdb: 1019] [UniProtKB: O15245]
ChEMBL Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy B 4.57 pIC50 27200 nM IC50 J Med Chem (2008) 51: 5932-5942 [PMID:18788725]
β1-adrenoceptor in Human [GtoPdb: 28] [UniProtKB: P08588]
GtoPdb - - 9.6 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
FASEB J (2011) 25: 4486-97 [PMID:21865315];
PLoS One (2013) 8: e77582 [PMID:24250787];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653]
GtoPdb - - 9.6 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
FASEB J (2011) 25: 4486-97 [PMID:21865315];
PLoS One (2013) 8: e77582 [PMID:24250787];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653]
GtoPdb - - 9.5 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
FASEB J (2011) 25: 4486-97 [PMID:21865315];
PLoS One (2013) 8: e77582 [PMID:24250787];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653]
β2-adrenoceptor in Human [GtoPdb: 29] [UniProtKB: P07550]
GtoPdb - - 10.2 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
FASEB J (2011) 25: 4486-97 [PMID:21865315];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653]
GtoPdb - - 10.3 pKi - - - Annu Rev Pharmacol Toxicol (1997) 37: 421-50 [PMID:9131260];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
FASEB J (2011) 25: 4486-97 [PMID:21865315];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653]
GtoPdb - - 9.8 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653]
β3-adrenoceptor in Human [GtoPdb: 30] [UniProtKB: P13945]
GtoPdb - - 8 pKi - - - PLoS ONE (2010) 5: e15487 [PMID:21152092];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Fundam Clin Pharmacol (1995) 9: 211-8 [PMID:7557816]
GtoPdb - - 8 pKi - - - Br J Pharmacol (1994) 112: 911-9 [PMID:7921620];
PLoS ONE (2010) 5: e15487 [PMID:21152092];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Fundam Clin Pharmacol (1995) 9: 211-8 [PMID:7557816]
GtoPdb - - 8.2 pEC50 - - - Br J Pharmacol (1994) 112: 911-9 [PMID:7921620];
PLoS ONE (2010) 5: e15487 [PMID:21152092];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Fundam Clin Pharmacol (1995) 9: 211-8 [PMID:7557816]
β3-adrenoceptor in Mouse [GtoPdb: 30] [UniProtKB: P25962]
GtoPdb - - 7.7 pKi - - - Br J Pharmacol (1994) 112: 911-9 [PMID:7921620]
GtoPdb - - 7.7 pKi - - - Br J Pharmacol (1994) 112: 911-9 [PMID:7921620]
GtoPdb - - 7.4 pEC50 - - - Br J Pharmacol (1994) 112: 911-9 [PMID:7921620]

ChEMBL data shown on this page come from version 37:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]